Nordhealth AS - Publication of Information Document
The attached information document has been prepared by Nordhealth AS (the "Company") solely for use in connection with the admission to trading of the Company's class A shares on Euronext Growth Oslo, commencing on 3 June 2021.
Carnegie AS has acted as the Company's Euronext Growth Advisor. Advokatfirmaet Thommessen AS has acted as legal counsel to the Company, and Advokatfirmaet Haavind AS has acted as legal counsel to the Euronext Growth Advisor in connection with the admission to trading.
For further information, please contact:
Charles MacBain, CEO
charles.macbain@nordhealth.com
+44 75 3903 2200
Valter Pasanen, CFO
+358 50 560 9286
About Nordhealth
Nordhealth is a cloud-based healthcare SaaS company whose mission is to redefine digital healthcare. The Company’s products empower healthcare professionals to improve patient care, increase efficiency and expand their business. Since 2005, the Company has acquired and built cloud-based software for veterinary and therapeutic professionals and their patients, and now serves more than 30,000 professionals across 7,000 clinics and hospitals located in over 25 countries.
Headquartered in Espoo, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 240 employees working either remotely or from offices (collaboration hubs), serving a global customer base. Visit the company’s website at nordhealth.com.
